Maintenance of endometriosis-associated pain reduction and quality of life improvement in phase 3 extension studies with elagolix
article
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Elagolix effectively maintained endometriosis-associated pain reduction and improved quality of life for patients in open-label, long-term extension studies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment 2019
- Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials 2020
- Correlates of Sexual Function in a Sample of Spanish Women with Endometriosis 2021
- Deep infiltrative endometriosis. Contentious issues: pros and cons 2020
Cited by (4)
- Correlates of Sexual Function in a Sample of Spanish Women with Endometriosis 2021
- Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials 2020
- Deep infiltrative endometriosis. Contentious issues: pros and cons 2020
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment 2019
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-18T06:36:33.011116+00:00
License: CC0
· commercial use OK